Nektar Therapeutics (NKTR) Reports Q4 Loss of $0.21
Tweet
Share
E-mail
Get Alerts NKTR Hot Sheet
Price: $70.68 -0.13%
EPS Growth %: +26.6%
Financial Fact:
Provision for income taxes: 139K
Today's EPS Names:
QCOM, QCOM, TIPT, More
EPS Growth %: +26.6%
Financial Fact:
Provision for income taxes: 139K
Today's EPS Names:
QCOM, QCOM, TIPT, More
Join SI Premium – FREE
Nektar Therapeutics (NASDAQ: NKTR) reported Q4 EPS of ($0.21), versus ($0.28) reported last year. Revenue for the quarter came in at $95.5 million, versus $37.5 million reported last year.
For earnings history and earnings-related data on Nektar Therapeutics (NKTR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Benchmark Electronics (BHE) Tops Q2 EPS by 16c; offers guidance
- Vista Gold Corp (VGZ) Reports Q2 Loss of $0.02
- Franklin BSP Realty Trust, Inc. (FBRT) Misses Q2 EPS by 12c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
